Granisetron Granisetron Granisetron Granisetron Granisetron Granisetron
Granisetron
Granisetron Granisetron Granisetron Granisetron Granisetron

Granisetron

600 INR/Gram

Product Details:

  • Particle Size 10 MICRON
  • Heavy Metal (%) 0.5 %
  • Storage Room Temperature
  • Structural Formula C18H24N4O
  • Smell Resinous
  • Molecular Weight 312.41 Grams (g)
  • Loss on Drying 0.5 %
  • Supply Ability : 100 Gram Per Week
  • Click to view more
X

Price And Quantity

  • 100 Gram
  • 600 INR/Gram

Product Specifications

  • ANTIVOMETTING
  • Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors.
  • Powder
  • Room Temperature
  • Medicine Grade
  • 10 MICRON
  • 0.5 %
  • 109889-09-0
  • C18H24N4O
  • 99.8 %
  • Odorless
  • 0.5 %
  • 36 Months
  • Granisetron
  • Resinous
  • White crystalline powder
  • 312.41 Grams (g)

Trade Information

  • Navaseva
  • Days after Acceptance (DA), Delivery Point (DP), Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Western Union, Paypal, Cash Against Delivery (CAD), Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID), Cheque
  • 100 Gram Per Week
  • 2 Days
  • Yes
  • Free samples are available
  • Double LDPE Liners in HDPE carboys
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India, Sikkim, Kerala, Mizoram, Madhya Pradesh, Karnataka, East India, Gujarat, Goa, Rajasthan, West Bengal, Chhattisgarh, Jammu and Kashmir, Odisha, Delhi, Manipur, Jharkhand, Daman and Diu, Arunachal Pradesh, Haryana, Andhra Pradesh, Meghalaya, North India, Assam, Tripura, Lakshadweep, Nagaland, Dadra and Nagar Haveli, Pondicherry, West India, Uttarakhand, Telangana, Bihar, Punjab, Chandigarh, Central India, South India, Himachal Pradesh, Maharashtra, Uttar Pradesh, Andaman and Nicobar Islands, Tamil Nadu
  • FDCA, GMP, GLP AND ISO

Product Description

It falls into the class of 5-HT3 receptor antagonists. Serotonin is a natural substance that may cause nausea and vomiting, and Granisetron prevents nausea and vomiting by blocking it. Granisetron is used to treat vomiting and nausea associated with chemotherapy. It has no effect on motion sickness or dopamine receptors. 

Granisetron belongs to the class of 5-HT3 receptor antagonist. Granisetron prevents nausea and vomiting by serotonin which is a natural substance which can cause nausea and vomiting. 

Granisetron used as an antiemetic agent to treat vomiting and nausea in the treatment like chemotherapy. This drug did not have effect in motion sickness and it will not effect on dopamine receptors. 

SYNONYMS OF GRANISETRON:  Granisetron,Granisetronum 

IUPAC NAME: 1-Methyl-N-((1R, 3r, 5S)-9-methyl-9-azabicyclononan-3-yl)-1H-indazole-3-carboxamide 

CAS NO: 109889-09-0 

MOLECULAR FORMULA: C18H24N4O 

MOLECULAR MASS: 312.41 g/mol 

STORAGE OF GRANISETRON: Keep medication is cool and dry place, do not store in bathroom or kitchen. Keep all medication away from children and pets 

HOW TO USE: Granisetron comes in oral dosage form like tablet; it is consumed by mouth with water. Take the medicine 1hr before the chemotherapy. And take second dose after the 12hr interval of first dose. 

HOW GRANISETRON WORKS: Granisetron gives antiemetic activity by inhibiting the 5-HT3 receptor which are located in centrally and peripherally in the body. By this process the natural serotonin secretion inhibited and by this the nausea and vomiting is prevented. 

PHARMACOKINETICS OF GRANISETRON: The main absorption of Granisetron is done by the oral and it is rapid and complete. As the result of first pass metabolism the oral bioavaibility is reduced about 60%. The half-life of Granisetron in the cancer patients is 9-12hrs and in the normal patient the half-life is 4-6 hrs. The 48% excretion of Granisetron is done by urination and remaining will excreted in faces. 

SIDE EFFECTS OF GRANISETRON: There are some common side effects of Granisetron is headache, dizziness, fever, pain,redness and swelling on the injection point. Tell your doctor if you see side effects like stomach/abdominal pain, chest pain, fast irregular heartbeats,hallucination, loss of coordination, muscle pain etc. The allergic reactions by the Granisetron are rare but if you develop symptoms like rash, itching or irritation consult your doctor. 

PRECAUTIONS: Tell your doctor if you are allergic to Granisetron or its residues. Before using the Granisetron tell your doctor if you have any past related to stomach or intestinal problem like swelling or surgery. Tell your doctor if you have certain history related to heart problems. Talk to your doctor about taking Granisetron safely. 

CDSCO APPROVAL OF GRANISETRON: Granisetron tablets are approved by CDSCO in India in 05.07.2000

 

FORMULATIONS AVAILABLE IN MARKET:

Granisetron 1mg tablets

Granisetron 1mg/ml injection

Granisetron 2mgtablets

Granisetron 1mg/5ml injection

Granisetron 3mg/3ml injection

Granisetron 500mg tablets

 

Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk

 

REFERENCES: 

www.webmd.com

https://pubchem.ncbi.nlm.nih.gov

https://go.drugbank.com

https://cdscoonline.gov.in

https://www.wikipedia.org/

https://www.drugs.com

https://www.zaubacorp.com

https://www.practo.com/consult

 

 

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Active Pharmaceuticals Ingredients (API)' category



NIKSAN PHARMACEUTICAL All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.